SUTENT is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Sunitinib Malate.
Product ID | 63539-017_23a46318-098e-48f1-a0cf-413d6a546c73 |
NDC | 63539-017 |
Product Type | Human Prescription Drug |
Proprietary Name | SUTENT |
Generic Name | Sunitinib Malate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2006-01-26 |
Marketing Category | NDA / NDA |
Application Number | NDA021938 |
Labeler Name | U.S. Pharmaceuticals |
Substance Name | SUNITINIB MALATE |
Active Ingredient Strength | 13 mg/1 |
Pharm Classes | Protein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-06-05 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0069-0550 | SUTENT | Sunitinib malate |
0069-0770 | SUTENT | Sunitinib malate |
0069-0830 | SUTENT | Sunitinib malate |
0069-0980 | SUTENT | Sunitinib malate |
63539-017 | SUTENT | SUTENT |
63539-019 | SUTENT | SUTENT |
0093-8199 | Sunitinib Malate | Sunitinib Malate |
0093-8224 | Sunitinib Malate | Sunitinib Malate |
0093-8229 | Sunitinib Malate | Sunitinib Malate |
0093-8231 | Sunitinib Malate | Sunitinib Malate |
0378-6678 | Sunitinib Malate | sunitinib malate |
0378-6679 | Sunitinib Malate | sunitinib malate |
0378-6680 | Sunitinib Malate | sunitinib malate |
0378-6681 | Sunitinib Malate | sunitinib malate |
16714-676 | Sunitinib malate | Sunitinib malate |
16714-677 | Sunitinib malate | Sunitinib malate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SUTENT 78750554 3170173 Live/Registered |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2005-11-09 |
SUTENT 78639799 not registered Dead/Abandoned |
Pharmacia & Upjohn Company LLC 2005-05-31 |
SUTENT 76388649 2948764 Live/Registered |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2002-03-26 |